701 related articles for article (PubMed ID: 11140465)
21. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.
Sun D; Wekerle H
Nature; 1986 Mar 6-12; 320(6057):70-2. PubMed ID: 2419764
[TBL] [Abstract][Full Text] [Related]
22. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
Ponomarev ED; Shriver LP; Maresz K; Dittel BN
J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
[TBL] [Abstract][Full Text] [Related]
23. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
24. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis.
Muhallab S; Dahlman I; Wallström E
J Neuroimmunol; 2005 Apr; 161(1-2):155-61. PubMed ID: 15748954
[TBL] [Abstract][Full Text] [Related]
25. The immunopathology of chronic experimental allergic encephalomyelitis induced in rabbits with bovine proteolipid protein.
Sobel RA; van der Veen RC; Lees MB
J Immunol; 1986 Jan; 136(1):157-63. PubMed ID: 2415615
[TBL] [Abstract][Full Text] [Related]
26. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
Palma JP; Yauch RL; Lang S; Kim BS
J Immunol; 1999 Jun; 162(11):6543-51. PubMed ID: 10352270
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
28. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.
Bonetti B; Pohl J; Gao YL; Raine CS
J Immunol; 1997 Dec; 159(11):5733-41. PubMed ID: 9548518
[TBL] [Abstract][Full Text] [Related]
29. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
30. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
[TBL] [Abstract][Full Text] [Related]
31. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
32. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
Weinberg AD; Wegmann KW; Funatake C; Whitham RH
J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
34. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
[TBL] [Abstract][Full Text] [Related]
35. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
37. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
[TBL] [Abstract][Full Text] [Related]
38. Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice.
Göbel K; Bittner S; Ruck T; Budde T; Wischmeyer E; Döring F; Wiendl H; Meuth SG
J Immunol Methods; 2011 Mar; 367(1-2):27-32. PubMed ID: 21199659
[TBL] [Abstract][Full Text] [Related]
39. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
Raine CS; Cannella B; Duijvestijn AM; Cross AH
Lab Invest; 1990 Oct; 63(4):476-89. PubMed ID: 1700193
[TBL] [Abstract][Full Text] [Related]
40. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
Ferber IA; Brocke S; Taylor-Edwards C; Ridgway W; Dinisco C; Steinman L; Dalton D; Fathman CG
J Immunol; 1996 Jan; 156(1):5-7. PubMed ID: 8598493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
